Laboratory Co. of America (NYSE:LH – Get Free Report) issued an update on its FY 2024 earnings guidance on Thursday morning. The company provided EPS guidance of 14.450-15.350 for the period, compared to the consensus EPS estimate of 14.820. The company issued revenue guidance of $12.7 billion-$12.9 billion, compared to the consensus revenue estimate of […]
RWA Wealth Partners LLC raised its stake in shares of Laboratory Co. of America Holdings (NYSE:LH – Free Report) by 20.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 3,091 shares of the medical research company’s stock after purchasing an additional 525 shares […]
Duality Advisers LP bought a new position in Laboratory Co. of America Holdings (NYSE:LH – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 12,257 shares of the medical research company’s stock, valued at approximately $2,786,000. Several other institutional investors […]
Cooke & Bieler LP reduced its position in shares of Laboratory Co. of America Holdings (NYSE:LH – Free Report) by 2.5% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 672,345 shares of the medical research company’s stock after selling 17,371 shares during the […]
Calamos Advisors LLC lowered its position in shares of Laboratory Co. of America Holdings (NYSE:LH – Free Report) by 1.3% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 48,748 shares of the medical research company’s stock after selling 637 shares during the quarter. […]